Dec 17 (Reuters) - China's medical regulator has approved Eli Lilly's (LLY.N), opens new tab treatment for early Alzheimer's, providing patients with another option after Eisai (4523.T), opens new ...
What Eli Lilly (NYSE: LLY) is doing is far more impressive. While many investors may buy it for its growth potential, here's why it can also make for an exceptional dividend stock to buy and hold.
Eli Lilly's weight loss medicine recently beat Novo Nordisk's in a head-to-head study. Both companies have plenty more anti-obesity candidates in the pipeline. There are many excellent reasons to ...
Eli Lilly has become one of the world's most influential pharmaceutical companies. That's thanks to its weight-loss medications, but it has other opportunities now as well. A recent announcement ...
This Friday will see the first season of Apple TV+’s psychological thriller Before come to an end, and while it will bring with it some fulfilling answers, fans will likely also be left with some ...
From original comedies to thrilling adventure series, the best anime of 2024 offered windows into deeply imagined and rigorously constructed worlds. In 2024, anime more than ever has felt like a ...